Back to search

France· FR:68356857

INDAPAMIDE EG LP 1,5 mg, comprimé pelliculé à libération prolongée

A indapamide product containing indapamide, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C03BA11

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedINDAPAMIDE EG LP 1,5 mg, comprimé pel…ATCC03BA11REGISTER NO.FR:68356857PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Indapamide is registered in 16 of 19 countries.

Countries holding a registration under ATC C03BA11 (indapamide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Indapamide · ATC C03BA11

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of indapamide costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.16 in Spain to $0.58 in Switzerland — a ×3.7 gap.

  • France: $0.26 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Indapamide · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.58
  • FR France$0.26
  • IT Italy$0.17
  • ES Spain$0.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
INDAPAMIDE
Manufacturer
EG LABO - LABORATOIRES EUROGENERICS
Country
France (FR)
ATC code
C03BA11
ATC class
Indapamide
Defined daily dose
2.5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400938547771
    plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)
    EUR 4.14
  • cip13
    3400938548143
    plaquette(s) thermoformée(s) PVC-Aluminium de 90 comprimé(s)
    EUR 11.53

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

347 interactions on record for indapamide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Indapamide · interactions on record

347 records

  • 4 severe
  • 208 moderate
  • 18 minor
  • 69 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Aminolevulinic acidL01XD04severe
  • Arsenic trioxideL01XX27severe

48 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Indapamide in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indapamide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Fludex Retard, Indapamid Krka
  • Belgium · Fludex, Indapamide Eg
  • Bulgaria · Индипам, Индипам Sr
  • Cyprus · Fludex
  • Czechia · Indap, Indapamid Pmcs
  • Germany · Indapamid Al, Indapamid Heumann
  • Denmark · Indapamid Holsten, Indapamid Stada
  • Estonia · Indamax, Indapamide Servier
  • Spain · Indapamida Normon, Indapamida Retard Cinfa
  • Finland · Indapamide Orion, Natrilix
  • United Kingdom (Northern Ireland) · Aprodip, Diurelix Xl
  • Greece · Fludex
  • Croatia · Indamid Sr, Indapamide Sr Pliva
  • Hungary · Apadex, Indastad
  • Ireland · Icorvida Sr, Natrilix Sr
  • Italy · Indapamide Aurobindo, Indapamide Doc Generici
  • Lithuania · Indamax, Indapen Sr
  • Luxembourg · Fludex, Indapamide Eg
  • Latvia · Indamax, Indapen Sr
  • Malta · Natrilix
  • Netherlands · Fludex, Indapamide Cf
  • Poland · Diuresin Sr, Indap
  • Portugal · Fludex, Fluidema
  • Romania · Iduren Sr, Impamid Sr
  • Slovenia · Indofort, Rawel Sr
  • Slovakia · Apadex, Indap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f83240ec-325a-4f9e-9379-2f030d08e94e
GET /v1/drugs/f83240ec-325a-4f9e-9379-2f030d08e94e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68356857",
  "date_amm": "2008-05-19",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "INDAPAMIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about indapamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.